To Prevent and Treat Infections



Armis Biopharma is a biopharmaceutical company with a growing pipeline of non-systemic, non-resistant anti-infective therapeutics designed to address antibiotic resistance and healthcare-associated infections, a serious and rapidly growing phenomenon.

Our mission is to decrease the quantity and severity of infections that cause human suffering and death through the creation and development of novel, targeted, antimicrobial therapies:

The Company’s lead technology, Veriox™ , is a first-of-its-kind, proprietary peracid/hydrogen peroxide based non-systemic, non-resistant antimicrobial agent. Veriox™ features an undefeatable Mechanism of Action (M of A) effective against Gram+, Gram-, viral, fungal and chemical/biological warfare pathogens.

Veriox™ has numerous healthcare applications: Surface Disinfectant (i.e., hospital rooms, operating suites, intensive care units, respirators etc.) Coatings (i.e., orthopedic implants) Embedded (i.e., surgical mesh, catheters etc.) Soft Tissue (i.e., acute wounds, skin infections etc.).

High concentration of
active agent with low
systemic exposure
Prophylactic and
therapeutic efficacy
Reduced cost of care to
hospitals, insurers,
and patients
Versatile platforms in the war
on resistant and preventable
Learn More


Armis is focused on highly efficacious, non-systemic antimicrobials that work as monotherapies and/or may increase the efficacy of existing systemic antibiotics.

Learn More

Leadership Team


Contact Us to learn more